90 related articles for article (PubMed ID: 34638872)
1. Cyclopeptide moroidin inhibits vasculogenic mimicry formed by glioblastoma cells
Min P; Li Y; Wang C; Fan J; Liu S; Chen X; Tang Y; Han F; Zhang A; Feng L
J Biomed Res; 2024 May; ():1-11. PubMed ID: 38807414
[TBL] [Abstract][Full Text] [Related]
2. Leptin Promotes Vasculogenic Mimicry in Breast Cancer Cells by Regulating Aquaporin-1.
Han DS; Lee EO
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791252
[TBL] [Abstract][Full Text] [Related]
3. Pseudogene MAPK6P4-encoded functional peptide promotes glioblastoma vasculogenic mimicry development.
Zhang M; Zhao Y; Liu X; Ruan X; Wang P; Liu L; Wang D; Dong W; Yang C; Xue Y
Commun Biol; 2023 Oct; 6(1):1059. PubMed ID: 37853052
[TBL] [Abstract][Full Text] [Related]
4. Glioblastoma-derived tumor cells induce vasculogenic mimicry through Flk-1 protein activation.
Francescone R; Scully S; Bentley B; Yan W; Taylor SL; Oh D; Moral L; Shao R
J Biol Chem; 2012 Jul; 287(29):24821-31. PubMed ID: 22654102
[TBL] [Abstract][Full Text] [Related]
5. SNORD17-mediated KAT6B mRNA 2'-O-methylation regulates vasculogenic mimicry in glioblastoma cells.
Cui J; Liu X; Dong W; Liu Y; Ruan X; Zhang M; Wang P; Liu L; Xue Y
Cell Biol Toxicol; 2023 Dec; 39(6):2841-2860. PubMed ID: 37058271
[TBL] [Abstract][Full Text] [Related]
6. DPY19L3 promotes vasculogenic mimicry by its
Baydoun H; Kato Y; Kamo H; Hüsch A; Mizuta H; Kawahara R; Simizu S
Oncol Res; 2024; 32(4):607-614. PubMed ID: 38560568
[No Abstract] [Full Text] [Related]
7. FOXC2 promotes vasculogenic mimicry and resistance to anti-angiogenic therapy.
Cannell IG; Sawicka K; Pearsall I; Wild SA; Deighton L; Pearsall SM; Lerda G; Joud F; Khan S; Bruna A; Simpson KL; Mulvey CM; Nugent F; Qosaj F; Bressan D; ; Dive C; Caldas C; Hannon GJ
Cell Rep; 2023 Aug; 42(8):112791. PubMed ID: 37499655
[TBL] [Abstract][Full Text] [Related]
8. II. Capsular vaso-mimicry formed by transgenic mammary tumor spheroids implanted ectopically into mouse dorsal skin fold: implications for cellular mechanisms of metastasis.
Witkiewicz H; Oh P; Schnitzer JE
F1000Res; 2013; 2():9. PubMed ID: 24555024
[TBL] [Abstract][Full Text] [Related]
9. A nano-platform combats the "attack" and "defense" of cytoskeleton to block cascading tumor metastasis.
Tao J; Yao Y; Huang M; Wu J; Lyu J; Li Q; Li L; Huang Y; Zhou Z
J Control Release; 2024 Mar; 367():572-586. PubMed ID: 38301926
[TBL] [Abstract][Full Text] [Related]
10. N6-isopentenyladenosine inhibits aerobic glycolysis in glioblastoma cells by targeting PKM2 expression and activity.
Pagano C; Coppola L; Navarra G; Avilia G; Savarese B; Torelli G; Bruzzaniti S; Piemonte E; Galgani M; Laezza C; Bifulco M
FEBS Open Bio; 2024 May; 14(5):843-854. PubMed ID: 38514913
[TBL] [Abstract][Full Text] [Related]
11. N6-Isopentenyladenosine Impairs Mitochondrial Metabolism through Inhibition of EGFR Translocation on Mitochondria in Glioblastoma Cells.
Pagano C; Coppola L; Navarra G; Avilia G; Bruzzaniti S; Piemonte E; Galgani M; Della Monica R; Chiariotti L; Cuomo M; Buonaiuto M; Torelli G; Caiazzo P; Laezza C; Bifulco M
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551529
[TBL] [Abstract][Full Text] [Related]
12. Glioblastoma-Specific Strategies of Vascularization: Implications in Anti-Angiogenic Therapy Resistance.
Buccarelli M; Castellani G; Ricci-Vitiani L
J Pers Med; 2022 Oct; 12(10):. PubMed ID: 36294763
[TBL] [Abstract][Full Text] [Related]
13. Physicochemical aspects of the tumour microenvironment as drivers of vasculogenic mimicry.
Andreucci E; Peppicelli S; Ruzzolini J; Bianchini F; Calorini L
Cancer Metastasis Rev; 2022 Dec; 41(4):935-951. PubMed ID: 36224457
[TBL] [Abstract][Full Text] [Related]
14. N6-isopentenyladenosine induces cell death through necroptosis in human glioblastoma cells.
Pagano C; Navarra G; Coppola L; Avilia G; Pastorino O; Della Monica R; Buonaiuto M; Torelli G; Caiazzo P; Bifulco M; Laezza C
Cell Death Discov; 2022 Apr; 8(1):173. PubMed ID: 35393392
[TBL] [Abstract][Full Text] [Related]
15. N6-Isopentenyladenosine Hinders the Vasculogenic Mimicry in Human Glioblastoma Cells through Src-120 Catenin Pathway Modulation and RhoA Activity Inhibition.
Pagano C; Navarra G; Pastorino O; Avilia G; Coppola L; Della Monica R; Chiariotti L; Florio T; Corsaro A; Torelli G; Caiazzo P; Gazzerro P; Bifulco M; Laezza C
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638872
[TBL] [Abstract][Full Text] [Related]
16. p120-Catenin prevents neutrophil transmigration independently of RhoA inhibition by impairing Src dependent VE-cadherin phosphorylation.
Alcaide P; Martinelli R; Newton G; Williams MR; Adam A; Vincent PA; Luscinskas FW
Am J Physiol Cell Physiol; 2012 Aug; 303(4):C385-95. PubMed ID: 22648953
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
